The handling of anti-cancer drugs in elderly patients;Le maniement des médicaments anticancéreux chez les malades âgés

Presse Medicale

Volumn 34, Issue 9, 2005, Pages 673-680

  Gaujard, Sylvain ^a   Albrand, Gilles ^a   Bonnefoy, Marc ^b   Courpron, Philippe ^a   Freyer, Gilles ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYTARABINE; DACARBAZINE; FLUDARABINE; HYDROXYUREA; IFOSFAMIDE; MELPHALAN; METHOTREXATE;

AGED; AGING; CANCER CHEMOTHERAPY; DRUG EFFICACY; DRUG METABOLISM; GERIATRIC PATIENT; HUMAN; ONCOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 20144367347     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)84012-6     Document Type: Review

References (72)

1. Sargent DJ, Goldberg RM, Jacobson SD, Mac Donald JS, Labianca R, Haller DG et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345: 1091-7.
2. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. The Oncologist 2000; 5: 224-37.
3. Terret C. Management and geriatric assessment of cancer in the elderly. Expert Rev Anticancer Ther 2004; 4: 469-75.
4. Silagy CA, Salem HH, Campion K, Mac Neil JJ, Robert J, Donnan GA et al. Haematological profile of healthy elderly Australians. Med J Aust 1992; 157: 96-100.
5. Balducci L, Hardy CL, Lyman GH. Hemopoietic reserve in the older cancer patient: clinical and economic considerations. Cancer Control 2000; 7: 539-47.
6. Kimmick GG, Fleming R, Muss HB, Balducci L. Cancer chemotherapy in older adults. A tolerability perspective. Drugs Aging 1997; 10: 34-49.
7. Lichtman SM. Guidelines for the treatment of elderly cancer patients. Cancer Control 2003; 10: 445-53.
8. Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyrand P, Tjan-Heijnen VC et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003; 39: 2264-72.
9. Stein BN, Petrelli NJ, Douglass HO, Driscoll DL, Arcangeli G, Meropol NJ. Age and sex are independant predictors of 5-flurouracil toxicity. Analysis of a large scale phase III trial. Cancer 1995; 75: 11-17.
10. Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol North Am 2000; 14: 1-16.
11. Borkowski JM, Durr M, Donehower RC, Rowinsky EK, Chen TL, Ettinger DS et al. Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacocinetik data. Cancer Chemother Pharmacol 1994; 33: 493-6.
12. Giovanazzi-Bannon S, Rademaker A, Lai G, Benson AB 3rd. Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois cancer study. J Clin Oncol 1994; 12: 2447-52.
13. Naeim A, Reuben D. Geriatric syndromes and assessment in older cancer patients. Oncology 2001; 15: 1567-77.
14. Chen H, Cantor A, Meyer J, Beth Corcoran M, Grendys E, Cavanaugh D et al. Can older patients tolerate chimiotherapy? A prospective pilot study. Cancer 2003; 97: 1107-14.
15. Fu A, Sreekumaran Nair K. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol 1998; 275: 1023-30.
16. Lichtman SM, Skirvin JA, Vemulapalli S. Pharmacology of antineoplastic agents in older cancer patients. Crit Rev Oncol Hematol 2003; 46: 101-14.
17. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-63.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
19. Jelliffe RW. Estimation of creatinine clearance when urine cannot be collected. Lancet 1971; 1: 975-6.
20. Smythe M, Hoffman J, Kizy K, Dmuchowski C. Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. Am J Hosp Phar 1994; 51: 198-204.
21. Marx GM, Blake GM, Galani E, Steer CB, Harper SE, Adamson KL et al. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 2004; 15: 291-5.
22. Bruno R, Hille D, Riva A, Vivier N, Ten Bokkel Huinnink WW, Van Oosterom AT, Kaye SB et al. Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. J Clin Oncol 1998; 16: 187-96.
23. Ralph LD, Thomson AH, Dobbs NA, Twelves C. A population model of epirubicin pharmacokinetics and application to dosage guidelines. Cancer Chemother Pharmacol 2003; 52: 34-40.
24. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 yeras of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061-7.
25. Skirvin JA, Lichtman SM. Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Drugs Aging 2002; 19: 25-42.
26. Liu G, Franssen E, Fitch MI, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 1997; 15: 110-15.
27. Jackson GH, Taylor PR, Iqbal A, Galloway MJ, Turner G, Haynes A et al. The use of an all oral chemotherapy (idarubicin and etoposide) in the treatment of acute myeloid leukaemia in the elderly: a report of toxicity and efficacy. Leukemia 1997; 11: 1193-6.
28. Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR et al. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer 2004; 43: 345-53.
29. Urquhart J. Patient compliance with crucial drug regimens: implications for prostate cancer. Eur Urol 1996; 29: 124-31.
30. Kemeny MM, Peterson BL, Kornblith AB, Muss HB, Wheeler J, Levine E et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003; 21: 2268-75.
31. Kornblith AB, Kemeny M, Peterson BL, Wheeler J, Crawford J, Bartlett N et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 2002; 95: 989-96.
32. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003; 21: 3580-7.
33. Holmes F. Clinical evidence for changes in tumor aggressiveness with age. In: Comprehensive geriatric oncology. Balducci L, Lyman GH, Ershler WB. Harwood Academic Publishers, Amsterdam, 1998: 223-8.
34. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer. J Natl Cancer Inst 1999; 91: 66-72.
35. Bloomfield DJ, Krahn MD, Neogi T, Panzarella T, Smith TJ, Warde P et al. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. J Clin Oncol 1998; 16: 2272-9.
36. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-6.
37. American Geriatric Society Public Policy Comittee. Comprehensive geriatric assessment. J Am Geriatr Soc 1989; 37: 473-4.
38. Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL. Effectiveness of a geriatric evaluation unit. A randomized Clinical Trial. N Engl J Med 1984; 311: 1664-70.
39. Rubenstein LZ, Wieland GD, Josephson KRE, Rosbrook B, Sayre J, Kane RL. Improved survival for frail elderly inpatients on a geriatric unit (GEU): Who benefits? J Clin Epidemiol 1988; 5: 441-9.
40. Stuck AE, Siu AL, Wieland GD, Rubinstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342: 1032-6.
41. Applegate WB, Akins D, Zwaag RV, Thoni K, Baker MG. A Geriatric rehabilitation and assessment unit in a community hospital. J Am Geriatr Soc 1983; 31: 206-10.
42. Rubenstein LZ, Abrass IB, Kane RL. Improved care for patients on a new geriatric evaluation unit. J Am Genatr Soc 1981; 29: 531-6.
43. Fields SD. History taking in the elderly: obtaining useful information. Geriatrics 1991; 46: 26-35.
44. Fields SD. Special consideration in the physical exam of older patients. Geriatrics 1991; 46: 39-44.
45. Vellas BJ, Albarede JL. Nutritional assessment as part of the geriatric evaluation: the mini-nutritional assessment. Facts and Research in Gerontology 1994; 52: 11-13.
46. Tinetti MA. Performance oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986; 34: 119-26.
47. Yesavage JA, Brick TL, Rose TL, Lum O, Huang V, Adey M et al. Development and validation of a geriatric depression scale: a preliminary report. J Psychiatry Res 1983; 17: 37-49.
48. Folstein MF, Folstein S, Mc Huth PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
49. Wood PHN. Comment mesurer les conséquences de la maladie: la classification internationale des infirmités, incapacités et handicaps. Chronique QMS 1980; 34: 400-5.
50. Reuben DB, Wieland DL, Rubenstein LZ. Functional status assessment of older persons: concepts and implications. Facts and Research in Gerontology 1993; 7: 367-77.
51. Katz S, Ford A, Moskowitz RW, Jakson BA, Jaffe MW. Studies illness in the aged: The index of ADL, a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-19.
52. Lawton MP, Brody EM. Assessement of older people: self-maintening and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
53. Reuben DB, Solomon DH. Assessment in geriatrics: of caveats and names. J Am Geriatr Soc 1989; 37: 570-2.
54. Reuben DB, Frank JC, Hirsch SH, McGuigan KA, Maly RC. A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations. J Am Geriatr Soc 1999; 47: 269-76.
55. Reuben DB, Maly RC, Hirsch SH, Frank JC, Oakes AM, Siu AL et al. Physician implementation of and patient adherence to recommendations from comprehensive geriatric assessment. Am J Med 1997; 100: 444-51.
56. Frank JC, Hirsch SH, Chernoff J, Wallace SP, Abrahamse A, Maly R et al. Determinants of patient adherence to consultative comprehensive geriatric assessment recommendations. J Gerontol A Biol Sci Med Sci 1997; 52: M44-M51.
57. Extermann M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 2003; 10: 463-8.
58. Terret C, Albrand G, Droz JP. Geriatric assessment in elderly patients with prostate cancer. Clin Prostate Cancer 2004; 2: 236-40.
59. Extermann M, Chen H, Cantor AB, Corcoran MB, Meyer J, Grendys E et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer 2002; 38: 1466-73.
60. Freyer G, Le Rol A, Weber B. Geriatric evaluation (GE) and feasability of platin-based first-line chemotherapy in elderly patients with advanced ovarian cancer (AOC). Proc Annu Meet Am Soc Clin Oncol 2002; 21: 1432 Abstract.
61. McCorkle R, Strumpf NE, Nuamah IF, Adler DC, Cooley ME, Jepson C et al. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatr Soc 2000; 48: 1707-13.
62. Monfardini S, Ferruci L, Fratino L, Del Lungo I, Serraino D, Zagonal V. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996; 77: 395-401.
63. Terret C, Gaujard S, Droz JP. Actualités en onco-gériatrie. Bull Cancer 2003; 90: 93-6.
64. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group Performance Status in elderly cancer patients: an Italian group for geriatric oncology study. J Clin Oncol 2002; 20: 494-502.
65. Lachs MS, Feinstein AR, Cooney LM Jr, Drickamer MA, Marottoli RA, Pannill FC et al. A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med 1990; 112: 699-706.
66. Balducci L, Yates J. General guidelines for the management of older patients with cancer. Oncology 2000; 14: 221-7.
67. Saliba D, Elliot M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001; 49: 1691-9.
68. Moore AA, Siu A, Partridge JM, Hays RD, Adams J. A randomized trial of office-based screening for common problems in older persons. Am J Med 1997; 102: 371-8.
69. Moore AA, Siu AL. Screening for common problems in ambulatory elderly: clinical confirmation of a screening instrument. Am J Med 1996; 100: 438-43.
70. Reuben DB, Siu AL. An objective measure of physical function of elderly out-patients. The Physical Performance Test. J Am Geriatr Soc 1990; 38: 1105-12.
71. Ganz PA, Reuben DB. Assessment of health status and outcomes: quality of life and geriatric assessment. In: Comprehensive geriatric oncology. Balducci L, Lyman GH, Ershler WB. Harwood Academic Publishers, Amsterdam, 1998: 521-41.
72. Extermann M, Bonetti M, Sledge GW, O'Dwyer PJ, Bonomi P, Benson AB 3rd. MAX2: a convenient index to estimate the average per patient risk for chemotherapy; validation in ECOG trials. Eur J Cancer 2004; 40: 1193-8.